Bayer AG - Strategy, SWOT and Corporate Finance Report
Bayer AG %li%Strategy, SWOT and Corporate Finance Report
Summary
Bayer AG %li%Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
Bayer AG (Bayer or 'the group') is a life science company that develops pharmaceutical, and chemical products. The company offers prescription and non-prescription medical products, cosmetics, seeds, plant traits, chemical, and biological crop protection products. It also offers products and solutions for the prevention and treatment of diseases in companion and farm animals. The company markets its products under Adalat, Redoxon, Baytril, Xofigo, Nativo, Serenade, Canesten, Afrin, Cydectin and Seresto brand names. Bayer distributes its products directly to farmers and through pharmacies, retailers, wholesalers, hospitals, veterinarians, supermarkets and drugstore chains. It has business presence in the Asia Pacific, Europe, North America, Latin America, Africa, and the Middle East. The company is headquartered in Leverkusen, Germany.
Scope
Summary
Bayer AG %li%Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
Bayer AG (Bayer or 'the group') is a life science company that develops pharmaceutical, and chemical products. The company offers prescription and non-prescription medical products, cosmetics, seeds, plant traits, chemical, and biological crop protection products. It also offers products and solutions for the prevention and treatment of diseases in companion and farm animals. The company markets its products under Adalat, Redoxon, Baytril, Xofigo, Nativo, Serenade, Canesten, Afrin, Cydectin and Seresto brand names. Bayer distributes its products directly to farmers and through pharmacies, retailers, wholesalers, hospitals, veterinarians, supermarkets and drugstore chains. It has business presence in the Asia Pacific, Europe, North America, Latin America, Africa, and the Middle East. The company is headquartered in Leverkusen, Germany.
Scope
- Detailed information on Bayer AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bayer AG in the form of a SWOT analysis
- An in-depth view of the business model of Bayer AG including a breakdown and examination of key business segments
- Intelligence on Bayer AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bayer AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Bayer AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bayer AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Bayer AG's business structure, strategy and prospects.
Company Snapshot
Bayer AG: Company Overview
Bayer AG: Overview and Key Facts
Bayer AG: Overview
Bayer AG: Key Facts
Bayer AG: Key Employees
Bayer AG: Key Employee Biographies
Bayer AG: Major Products and Services
Bayer AG: Management Statement
Bayer AG: Locations and Subsidiaries
Bayer AG: Key Competitors
Bayer AG: Company Analysis
Bayer AG: Business Description
Bayer AG: SWOT Analysis
Bayer AG: SWOT Overview
Bayer AG: Strengths
Bayer AG: Weaknesses
Bayer AG: Opportunities
Bayer AG: Threats
Bayer AG: Corporate Financial Deals Activity
Bayer AG: Financial Deals Overview
Bayer AG: Targets and Partners
Bayer AG: Top Deals 2019 - 2023YTD*
Bayer AG: Advisors
Bayer AG: Top Legal Advisors
Bayer AG: Top Financial Advisors
Bayer AG: Mergers and Acquisitions
Bayer AG: Corporate Venturing
Bayer AG: Capital Raising
Bayer AG: Partnership
Bayer AG: Divestments
Bayer AG: Private Equity and Ownership
Bayer AG: Recent Developments
Bayer AG: News and Events Summary
Bayer AG: Contracts
Bayer AG: Market Developments
Bayer AG: Regulatory and Legal Events
Bayer AG: Research & Development
Bayer AG: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
LIST OF TABLES
Table 1: Bayer AG: Key Facts
Table 2: Bayer AG: Key Employees
Table 3: Bayer AG: Locations and Subsidiaries
Table 4: Bayer AG: Key Competitors
Table 5: Bayer AG: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Bayer AG: M&A Activity by Geography (TTM*)
Table 7: Bayer AG: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: Bayer AG: M&A Average Deal Size - Value (US$m)
Table 9: Bayer AG: Targets and Partners
Table 10: Bayer AG: Top Deals 2019 - 2023YTD*
Table 11: Bayer AG: Legal Advisor Ranking by Value (US$m)
Table 12: Bayer AG: Financial Advisor Ranking by Value (US$m)
Table 13: Bayer AG: M&A Volume and Value Trend (2019 - YTD*2023)
Table 14: Bayer AG: M&A Activity by Geography (2019 - YTD*2023)
Table 15: Bayer AG: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 16: Bayer AG: Corporate Venturing by Geography (2019 - YTD*2023)
Table 17: Bayer AG: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 18: Bayer AG: Capital Raising by Deal Type (2019 - YTD*2023)
Table 19: Bayer AG: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 20: Bayer AG: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 21: Bayer AG: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 22: Bayer AG: Divestments by Geography (2019 - YTD*2023)
Table 23: Bayer AG: Private Equity and Ownership Volume and Value Trend (2019 - YTD*2023)
Table 24: Bayer AG: Private Equity and Ownership Volume by Deal Type (2019 - YTD*2023)
Table 25: Bayer AG: News and Events Summary
Table 26: Bayer AG: Contracts
Table 27: Bayer AG: Market Developments
Table 28: Bayer AG: Regulatory and Legal Events
Table 29: Bayer AG: Research & Development
Table 30: Bayer AG: Strategy and Operations
Table 1: Bayer AG: Key Facts
Table 2: Bayer AG: Key Employees
Table 3: Bayer AG: Locations and Subsidiaries
Table 4: Bayer AG: Key Competitors
Table 5: Bayer AG: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Bayer AG: M&A Activity by Geography (TTM*)
Table 7: Bayer AG: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: Bayer AG: M&A Average Deal Size - Value (US$m)
Table 9: Bayer AG: Targets and Partners
Table 10: Bayer AG: Top Deals 2019 - 2023YTD*
Table 11: Bayer AG: Legal Advisor Ranking by Value (US$m)
Table 12: Bayer AG: Financial Advisor Ranking by Value (US$m)
Table 13: Bayer AG: M&A Volume and Value Trend (2019 - YTD*2023)
Table 14: Bayer AG: M&A Activity by Geography (2019 - YTD*2023)
Table 15: Bayer AG: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 16: Bayer AG: Corporate Venturing by Geography (2019 - YTD*2023)
Table 17: Bayer AG: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 18: Bayer AG: Capital Raising by Deal Type (2019 - YTD*2023)
Table 19: Bayer AG: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 20: Bayer AG: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 21: Bayer AG: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 22: Bayer AG: Divestments by Geography (2019 - YTD*2023)
Table 23: Bayer AG: Private Equity and Ownership Volume and Value Trend (2019 - YTD*2023)
Table 24: Bayer AG: Private Equity and Ownership Volume by Deal Type (2019 - YTD*2023)
Table 25: Bayer AG: News and Events Summary
Table 26: Bayer AG: Contracts
Table 27: Bayer AG: Market Developments
Table 28: Bayer AG: Regulatory and Legal Events
Table 29: Bayer AG: Research & Development
Table 30: Bayer AG: Strategy and Operations
LIST OF FIGURES
Figure 1: Bayer AG: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Bayer AG: M&A Activity by Geography (TTM*)
Figure 3: Bayer AG: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 4: Bayer AG: M&A Average Deal Size - Value (US$m)
Figure 5: Bayer AG: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 6: Bayer AG: M&A Activity by Geography (2019 - YTD*2023)
Figure 7: Bayer AG: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 8: Bayer AG: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 9: Bayer AG: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 10: Bayer AG: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 11: Bayer AG: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 12: Bayer AG: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 13: Bayer AG: Divestments Volume and Value Trend (2019 - YTD*2023)
Figure 14: Bayer AG: Divestments by Geography (2019 - YTD*2023)
Figure 15: Bayer AG: Private Equity and Ownership Volume and Value Trend (2019 - YTD*2023)
Figure 16: Bayer AG: Private Equity and Ownership Volume by Deal Type (2019 - YTD*2023)
Figure 1: Bayer AG: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Bayer AG: M&A Activity by Geography (TTM*)
Figure 3: Bayer AG: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 4: Bayer AG: M&A Average Deal Size - Value (US$m)
Figure 5: Bayer AG: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 6: Bayer AG: M&A Activity by Geography (2019 - YTD*2023)
Figure 7: Bayer AG: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 8: Bayer AG: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 9: Bayer AG: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 10: Bayer AG: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 11: Bayer AG: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 12: Bayer AG: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 13: Bayer AG: Divestments Volume and Value Trend (2019 - YTD*2023)
Figure 14: Bayer AG: Divestments by Geography (2019 - YTD*2023)
Figure 15: Bayer AG: Private Equity and Ownership Volume and Value Trend (2019 - YTD*2023)
Figure 16: Bayer AG: Private Equity and Ownership Volume by Deal Type (2019 - YTD*2023)
